Abstract
• In situ pulmonary thrombosis may exist in COVID-19 pneumonia patients with the feature of peripheral distribution. • Some thrombi located just within the consolidation lesions of the infected lungs, likely due to active local inflammation. • Some thrombi located in non-consolidation area, likely due to hypercoagulability caused by systemic inflammation. • We hypothesize different phenotypes of in situ thrombosis may exist and need different intensity of anticoagulant therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
